Project Details
Status | Finished |
---|---|
Effective start/end date | 1/10/2014 → 30/09/2016 |
Collaborative partners
- King's College London (lead)
- University of Cambridge
- Janssen Pharmaceutica N.V.
- GSK GlaxoSmithKline Research & Development Ltd
- MRC Medical Research Council
Funding
- MRC Medical Research Council: £172,986.00